Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06892379 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of HS-20110 in Participants With Advanced Solid Tumors

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 6 to 8v7
  2. Collaborators expanded, about 2 wordsv6 See this version in full on ClinicalTrials.gov ↗
  3. Site details revised at 4 of 6 sitesv5
  4. Study sites: 3 to 6v4
  5. Study sites: 1 to 3v3
  6. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Mar 28, 2025 to Feb 26, 2025v2 Show 1 more changeShow less
    • Start date changed from estimate of Mar 28, 2025 to Feb 26, 2025
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an open-label, multicenter study to evaluate the safety and tolerability of HS-20110 in participants with advanced solid malignant tumors
Trial Details
NCT Number NCT06892379
Lead Sponsor Hansoh BioMedical R&D Company
Collaborators: Hoffmann-La Roche
Conditions Solid Tumors
Enrollment 475 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov